Insmed IncorporatedINSMNASDAQ
LOADING
|||
| Metric | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +18.15% | +24.79% | +22.94% | +18.90% | +52.36% |
| Gross Profit Growth | +15.86% | +19.99% | +23.26% | +14.36% | +15.72% |
| EBITDA Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Net Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Diluted Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Weighted Average Shares Growth | +21.57% | +23.63% | +21.83% | +22.37% | +21.90% |
| Weighted Average Shares Diluted Growth | +21.57% | +23.63% | +21.83% | +22.37% | +21.71% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Free Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Receivables Growth | +18.94% | +26.28% | +28.48% | +36.56% | +54.21% |
| Inventory Growth | +26.37% | +18.41% | +21.40% | +19.48% | +22.84% |
| Asset Growth | +54.96% | +52.29% | +55.53% | +37.00% | +14.99% |
| Book Value per Share Growth | +0.00% | +0.00% | +0.00% | +2531.03% | +60.47% |
| Debt Growth | -2.80% | -3.54% | -4.46% | -46.11% | -35.97% |
| R&D Expense Growth | +38.17% | +31.16% | +26.01% | +20.74% | +23.61% |
| SG&A Expenses Growth | +31.23% | +59.18% | +58.48% | +45.22% | +56.71% |